All patients
age >= 60 yr autoimmune disease invasive ventilation no oxygen needed non invasive oxygen
corticosteroids in COVID-19 severe or critically - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias death D28detailed results Jamaati, 2021 1.19 [0.38; 3.72]
1.19 [0.38 ; 3.72 ] Jamaati, 2021 1 0% 50 NA not evaluable deathsdetailed results CAPE-COVID, 2020 0.45 [0.20; 1.02]
CODEX (Tomazini), 2020 0.97 [0.72; 1.31]
DEXA-COVID19, 2020 2.00 [0.21; 18.87]
Jamaati, 2021 1.19 [0.38; 3.72]
Steroids-SARI, 2020 0.91 [0.29; 2.86]
0.91 [0.70 ; 1.19 ] CAPE-COVID, 2020, CODEX (Tomazini), 2020, DEXA-COVID19, 2020, Jamaati, 2021, Steroids-SARI, 2020 5 0% 563 moderate not evaluable clinical deteriorationdetailed results CODEX (Tomazini), 2020 0.66 [0.43; 1.02]
0.66 [0.43 ; 1.02 ] CODEX (Tomazini), 2020 1 0% 299 NA not evaluable death or ventilationdetailed results CAPE-COVID, 2020 0.71 [0.37; 1.35]
0.71 [0.37 ; 1.35 ] CAPE-COVID, 2020 1 0% 149 NA not evaluable hospital dischargedetailed results CAPE-COVID, 2020 1.67 [0.87; 3.19]
1.67 [0.87 ; 3.19 ] CAPE-COVID, 2020 1 0% 149 NA not evaluable mechanical ventilationdetailed results CAPE-COVID, 2020 0.95 [0.44; 2.04]
Jamaati, 2021 1.38 [0.45; 4.20]
1.07 [0.57 ; 2.01 ] CAPE-COVID, 2020, Jamaati, 2021 2 0% 199 low not evaluable radiologic improvement (14-day)detailed results Jamaati, 2021 4.89 [1.15; 20.79]
4.89 [1.15 ; 20.79 ] Jamaati, 2021 1 0% 50 NA not evaluable serious adverse eventsdetailed results CODEX (Tomazini), 2020 0.53 [0.17; 1.62]
0.53 [0.17 ; 1.62 ] CODEX (Tomazini), 2020 1 0% 299 NA not evaluable superinfectiondetailed results CAPE-COVID, 2020 0.81 [0.49; 1.34]
0.81 [0.49 ; 1.34 ] CAPE-COVID, 2020 1 0% 149 NA not evaluable 0.2 10.0 1.0 relative treatment effect www.metaEvidence.org 2025-03-09 15:27 +01:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1;
studied treatment is better when TE < 1;
pathologies: 91
- treatments: 522,582,666,1149,1150,737,544,733
- roots T: 290